{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:43:37Z","timestamp":1761803017837,"version":"build-2065373602"},"reference-count":132,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ccep.2017.07.009","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T20:01:10Z","timestamp":1511380870000},"page":"581-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sudden Cardiac Death in Genetic Cardiomyopathies"],"prefix":"10.1016","volume":"9","author":[{"given":"Gourg","family":"Atteya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Lampert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccep.2017.07.009_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/heart.84.1.106","article-title":"Diagnosis and management of dilated cardiomyopathy","volume":"84","author":"Elliott","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2017.07.009_bib2","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The diagnosis and evaluation of dilated cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib3","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.110.976092","article-title":"Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society workshop","volume":"122","author":"Fishman","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1750-1172-1-27","article-title":"Cardiomyopathy, familial dilated","volume":"1","author":"Taylor","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ccep.2017.07.009_bib6","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijcard.2016.09.068","article-title":"Genetic basis of dilated cardiomyopathy","volume":"224","author":"Perez-Serra","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib8","doi-asserted-by":"crossref","first-page":"796926","DOI":"10.1155\/2012\/796926","article-title":"Cardiomyopathy classification: ongoing debate in the genomics era","volume":"2012","author":"McCartan","year":"2012","journal-title":"Biochem Res Int"},{"key":"10.1016\/j.ccep.2017.07.009_bib9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2004.11.066","article-title":"Clinical and genetic issues in familial dilated cardiomyopathy","volume":"45","author":"Burkett","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","article-title":"Atlas of the clinical genetics of human dilated cardiomyopathy","volume":"36","author":"Haas","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccep.2017.07.009_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/GIM.0b013e3181d6f7c0","article-title":"A\u00a0novel custom resequencing array for dilated cardiomyopathy","volume":"12","author":"Zimmerman","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.ccep.2017.07.009_bib13","doi-asserted-by":"crossref","first-page":"270ra6","DOI":"10.1126\/scitranslmed.3010134","article-title":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease","volume":"7","author":"Roberts","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ccep.2017.07.009_bib14","first-page":"1601","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.ccep.2017.07.009_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/CIRCEP.111.962050","article-title":"Dilated cardiomyopathy","volume":"6","author":"Lakdawala","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib17","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199412083312307","article-title":"Idiopathic dilated cardiomyopathy","volume":"331","author":"Dec","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccep.2017.07.009_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.amjcard.2015.06.022","article-title":"Contemporary outcome in patients with idiopathic dilated cardiomyopathy","volume":"116","author":"Broch","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib19","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2013.06.020","article-title":"Implantable cardioverter-defibrillators in lamin A\/C mutation carriers with cardiac conduction disorders","volume":"10","author":"Anselme","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2017.07.009_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00392-016-1033-6","article-title":"Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals","volume":"106","author":"Kayvanpour","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib21","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib22","doi-asserted-by":"crossref","first-page":"e0158730","DOI":"10.1371\/journal.pone.0158730","article-title":"Familial dilated cardiomyopathy caused by a novel frameshift in the BAG3 gene","volume":"11","author":"Toro","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ccep.2017.07.009_bib23","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jacc.2012.05.050","article-title":"R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy","volume":"60","author":"Mann","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib24","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jacc.2013.12.021","article-title":"Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy","volume":"63","author":"Goldberger","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2017.07.009_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ccep.2017.07.009_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCEP.116.004067","article-title":"Right ventricular ejection fraction is incremental to left ventricular ejection fraction for the prediction of future arrhythmic events in patients with systolic dysfunction","volume":"10","author":"Mikami","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12968-016-0255-0","article-title":"Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?","volume":"18","author":"Riffel","year":"2016","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.ccep.2017.07.009_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jchf.2016.11.009","article-title":"Primary prevention of sudden arrhythmic death in dilated cardiomyopathy: current guidelines and risk stratification","volume":"5","author":"Arbustini","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ccep.2017.07.009_bib29","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2012.12.017","volume":"61","author":"Russo","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib30","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/CIRCULATIONAHA.114.014444","article-title":"Prospective randomized trial of moderately strenuous aerobic exercise after an implantable cardioverter defibrillator","volume":"131","author":"Dougherty","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib31","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/heartjnl-2012-302145","article-title":"Exercise training in dilated cardiomyopathy improves rest and stress cardiac function without changes in cardiac high energy phosphate metabolism","volume":"98","author":"Holloway","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2017.07.009_bib32","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2009.457","article-title":"Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"Flynn","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ccep.2017.07.009_bib33","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jacc.2015.09.035","volume":"66","author":"Maron","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib34","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.csm.2015.03.005","article-title":"Sports and exercise in athletes with hypertrophic cardiomyopathy","volume":"34","author":"Alpert","year":"2015","journal-title":"Clin Sports Med"},{"key":"10.1016\/j.ccep.2017.07.009_bib36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ccep.2017.07.009_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrcardio.2011.159","article-title":"Mechanisms of disease: hypertrophic cardiomyopathy","volume":"9","author":"Frey","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib38","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.115.017633","article-title":"Hypertrophic cardiomyopathy in children, adolescents, and young adults associated with low cardiovascular mortality with contemporary management strategies","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy\u00a0>=60 years of age","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib41","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","article-title":"Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy","volume":"27","author":"Elliott","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib42","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/eurheartj\/ehp327","article-title":"Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy","volume":"30","author":"Gimeno","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib43","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib44","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccep.2017.07.009_bib45","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","article-title":"Syncope and risk of sudden death in hypertrophic cardiomyopathy","volume":"119","author":"Spirito","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.echo.2006.01.005","article-title":"Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy","volume":"19","author":"Sorajja","year":"2006","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.ccep.2017.07.009_bib47","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.amjcard.2010.06.077","article-title":"Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy","volume":"106","author":"Bos","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib48","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0002-9149(98)00455-X","article-title":"Predictors of sudden cardiac death in hypertrophic cardiomyopathy","volume":"82","author":"Maki","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib49","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1161\/01.CIR.96.9.2987","article-title":"Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy","volume":"96","author":"Sadoul","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib50","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amjcard.2015.05.047","article-title":"Independent assessment of the European Society of Cardiology sudden death risk model for hypertrophic cardiomyopathy","volume":"116","author":"Maron","year":"2015","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ccep.2017.07.009_bib52","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ccep.2017.07.009_bib53","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/heartjnl-2015-308453","article-title":"Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy","volume":"102","author":"Magri","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2017.07.009_bib54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.002248","article-title":"Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy","volume":"8","author":"Coats","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ccep.2017.07.009_bib55","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122","article-title":"Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with \u03b2-blockade or verapamil","volume":"6","author":"Sherrid","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ccep.2017.07.009_bib56","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jacc.2005.01.012","article-title":"Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy","volume":"45","author":"Sherrid","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib57","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.64.3.437","article-title":"Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy","volume":"64","author":"Epstein","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib58","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1536\/ihj.27.701","article-title":"Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy: double-blind crossover study","volume":"27","author":"Toshima","year":"1986","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib60","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jchf.2014.06.012","article-title":"Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy","volume":"2","author":"Vriesendorp","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ccep.2017.07.009_bib61","first-page":"1245","article-title":"Risk and causes of death in patients after alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"31","author":"Veselka","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib62","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jchf.2014.07.008","article-title":"Revisiting arrhythmic risk after alcohol septal ablation: is the pendulum finally swinging\u2026back to myectomy?","volume":"2","author":"Maron","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ccep.2017.07.009_bib63","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jcin.2014.05.023","article-title":"Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience","volume":"7","author":"Steggerda","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ccep.2017.07.009_bib64","first-page":"107","article-title":"A\u00a0meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy","volume":"88","author":"Singh","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ccep.2017.07.009_bib65","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jchf.2015.06.011","article-title":"A\u00a0systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy","volume":"3","author":"Liebregts","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ccep.2017.07.009_bib66","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ccep.2017.07.009_bib67","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/hrt.2010.217182","article-title":"The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy","volume":"98","author":"O'Mahony","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2017.07.009_bib68","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1540-8167.2009.01716.x","article-title":"Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up","volume":"21","author":"Syska","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib69","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0735-1097(89)90302-1","article-title":"Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest","volume":"13","author":"Cecchi","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib70","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(99)00056-X","article-title":"Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy","volume":"33","author":"Elliott","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib71","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccep.2017.07.009_bib72","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib73","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.108.804617","article-title":"Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006","volume":"119","author":"Maron","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib74","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1996.03540030033028","article-title":"Sudden death in young competitive athletes: clinical, demographic, and pathological profiles","volume":"276","author":"Maron","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ccep.2017.07.009_bib75","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/01.hjr.0000238393.96975.32","article-title":"Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis","volume":"13","author":"Pelliccia","year":"2006","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ccep.2017.07.009_bib76","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.112.000447","article-title":"Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry","volume":"127","author":"Lampert","year":"2013","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ccep.2017.07.009_bib77","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.117.027828","article-title":"Safety of sports for athletes with implantable cardioverter defibrillators: long-term results of a prospective multinational registry","volume":"135","author":"Lampert","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib78","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.amjcard.2012.12.018","article-title":"Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy","volume":"111","author":"Reineck","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib79","doi-asserted-by":"crossref","first-page":"e000484","DOI":"10.1136\/openhrt-2016-000484","article-title":"Physical inactivity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers","volume":"3","author":"Sweeting","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.ccep.2017.07.009_bib80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2047487313501277","article-title":"Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center","volume":"22","author":"Klempfner","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib81","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2011.06.054","article-title":"Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (exercise training in diastolic heart failure) pilot study","volume":"58","author":"Edelmann","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib82","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.2017.2503","article-title":"Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial","volume":"317","author":"Saberi","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ccep.2017.07.009_bib83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccep.2017.07.009_bib84","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCRESAHA.110.223412","article-title":"The cardiac desmosome and arrhythmogenic cardiomyopathies: from gene to disease","volume":"107","author":"Delmar","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.ccep.2017.07.009_bib85","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijcard.2003.10.037","article-title":"Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital","volume":"97","author":"Peters","year":"2004","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ccep.2017.07.009_bib86","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.hrthm.2017.02.013","article-title":"Cardiac phenotype and long term prognosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia patients with late presentation","volume":"14","author":"Bhonsale","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2017.07.009_bib87","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jacc.2014.12.041","article-title":"Importance of CMR within the task force criteria for the diagnosis of ARVC in children and adolescents","volume":"65","author":"Etoom","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib88","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.jacc.2006.07.045","article-title":"Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype","volume":"48","author":"Sen-Chowdhry","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib89","first-page":"215","article-title":"Diagnosis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"71","author":"William","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib90","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib91","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)02379-5","article-title":"Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)","volume":"355","author":"McKoy","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccep.2017.07.009_bib92","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ng1461","article-title":"Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Gerull","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.ccep.2017.07.009_bib93","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/humu.22765","article-title":"The ARVD\/C genetic variants database: 2014 update","volume":"36","author":"Lazzarini","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ccep.2017.07.009_bib94","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/CIRCULATIONAHA.105.583674","article-title":"Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy","volume":"113","author":"Pilichou","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib95","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/344208","article-title":"Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy","volume":"71","author":"Rampazzo","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ccep.2017.07.009_bib96","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/509122","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2","volume":"79","author":"Syrris","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ccep.2017.07.009_bib97","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ccep.2017.07.009_bib98","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib99","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1161\/CIRCULATIONAHA.110.976936","article-title":"Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria","volume":"123","author":"Quarta","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib100","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.jacc.2007.08.008","article-title":"Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"50","author":"Sen-Chowdhry","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib101","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib102","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ccep.2017.07.009_bib103","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/europace\/euv061","article-title":"Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy","volume":"18","author":"Protonotarios","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ccep.2017.07.009_bib104","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/europace\/euv205","article-title":"Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy","volume":"18","author":"Zorzi","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.ccep.2017.07.009_bib105","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jacc.2011.06.043","article-title":"Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention","volume":"58","author":"Bhonsale","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib106","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCULATIONAHA.109.913871","article-title":"Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia","volume":"122","author":"Corrado","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib107","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2014.04.035","article-title":"Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment","volume":"64","author":"Link","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib109","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.CIR.0000121738.88273.43","article-title":"Implantable cardioverter\/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients","volume":"109","author":"Wichter","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib110","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/eurheartj\/ehr040","article-title":"Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry","volume":"32","author":"Pinamonti","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib111","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/hrt.2004.038620","article-title":"Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy: long term experience of a tertiary care centre","volume":"91","author":"Lemola","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2017.07.009_bib112","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2459\/01.JCM.0000278450.35107.b3","article-title":"Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia\/cardiomyopathy: personal experience from different primary and tertiary centres","volume":"8","author":"Peters","year":"2007","journal-title":"J\u00a0Cardiovasc Med"},{"key":"10.1016\/j.ccep.2017.07.009_bib113","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/01.CIR.0000143375.93288.82","article-title":"Natural history and risk stratification of arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"110","author":"Hulot","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib114","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCIMAGING.113.000210","article-title":"Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"7","author":"Saguner","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.ccep.2017.07.009_bib115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCEP.111.974881","article-title":"Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"6","author":"Migliore","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib116","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.hrthm.2012.03.057","article-title":"Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study","volume":"9","author":"Santangeli","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2017.07.009_bib117","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCEP.113.000233","article-title":"Risk stratification in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"6","author":"Bhonsale","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib118","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.amjcard.2014.02.031","article-title":"Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia","volume":"113","author":"Saguner","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib119","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/eurheartj\/ehs383","article-title":"Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada","volume":"34","author":"Haywood","year":"2013","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ccep.2017.07.009_bib120","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003589","article-title":"Long-term clinical outcome of arrhythmogenic right ventricular cardiomyopathy in individuals with a p.S358L mutation in TMEM43 following implantable cardioverter defibrillator therapy","volume":"9","author":"Hodgkinson","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"Suppl D","key":"10.1016\/j.ccep.2017.07.009_bib121","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/eurheartj\/10.suppl_D.68","article-title":"Long-term follow-up in patients with arrhythmogenic right ventricular disease","volume":"10","author":"Marcus","year":"1989","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.CIR.86.1.29","article-title":"Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease: results in patients with inducible and noninducible ventricular tachycardia","volume":"86","author":"Wichter","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib123","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","article-title":"Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC registry","volume":"54","author":"Marcus","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib124","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s00380-006-0963-8","article-title":"Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"22","author":"Boriani","year":"2007","journal-title":"Heart Vessels"},{"key":"10.1016\/j.ccep.2017.07.009_bib125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/heart.85.1.53","article-title":"Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias","volume":"85","author":"Tavernier","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.ccep.2017.07.009_bib126","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/CIRCEP.113.000392","article-title":"Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications","volume":"6","author":"Schinkel","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib127","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0735-1097(97)00332-X","article-title":"Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a multicenter study","volume":"30","author":"Corrado","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib128","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2017.07.009_bib129","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/eurheartj\/ehv110","article-title":"Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Ruwald","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccep.2017.07.009_bib130","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1249\/MSS.0b013e31820607a3","article-title":"Disproportionate exercise load and remodeling of the athlete's right ventricle","volume":"43","author":"La Gerche","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ccep.2017.07.009_bib131","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.106.624502","article-title":"Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice","volume":"114","author":"Kirchhof","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2017.07.009_bib132","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hrthm.2015.08.035","article-title":"Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers","volume":"13","author":"Sawant","year":"2016","journal-title":"Heart Rhythm"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918217300953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918217300953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:39:24Z","timestamp":1761802764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918217300953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1877918217300953"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2017.07.009","relation":{},"ISSN":["1877-9182"],"issn-type":[{"type":"print","value":"1877-9182"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sudden Cardiac Death in Genetic Cardiomyopathies","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2017.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}